MDT

Healthcare Medical Devices

Medtronic plc

$87.97
-0.09 -0.10% today

Price History

Not enough data

Key Stats

Market Cap
112.53B
Avg Volume
10.04M
P/E (TTM)
21.61
EPS
$4.07
52W High
$106.33
52W Low
$73.31
Div. Yield
3.3%

Analyst Ratings

Buy
3
Str Buy
16
Buy
9
Hold
0
Sell
0
Str Sell

Valuation

Forward P/E
13.72
P/B Ratio
2.24
P/S Ratio
3.00
EV/EBITDA
12.73
EV/Revenue
3.53
PEG Ratio
1.55

Margins

Gross Margin 65.3%
Operating Margin 19.3%
Net Margin 13.9%
EBITDA Margin 27.7%

Growth & Returns

Revenue Growth (YoY)
13.7%
Earnings Growth (YoY)
40.7%
Earnings Growth (QoQ)
41.3%
Return on Equity
10.6%
Return on Assets
5.1%

Liquidity & Leverage

Current Ratio
2.07
Quick Ratio
1.29
Debt / Equity
0.55
Total Cash
8.82B
Total Debt
28.15B

About

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

www.medtronic.com